Showing results (351-360 of 412) with videos related to

Sort By:
Pageof 42
Targeted Oncology|July 29, 2021
Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced DifferentiationHaley E Ramsey, Kristy Stengel, James C Pino, et al.
Blood Advances|April 12, 2024
Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepositoryMorgan L Shannon, J Brett Heimlich, Sydney Olson, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibitionGregory C Howard, Jing Wang, Kristie Lindsey Rose, et al.
Blood|January 28, 2015
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsMichael R Savona, Luca Malcovati, Rami Komrokji, et al.
Blood|May 5, 2018
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemiaEytan M Stein, Guillermo Garcia-Manero, David A Rizzieri, et al.
Orthopaedic Journal of Sports Medicine|June 8, 2017
Outcome of Expedited Rotator Cuff Surgery in Injured Workers: Determinants of Successful RecoveryHelen Razmjou, Dragana Boljanovic, Sandra Lincoln, et al.
Lancet (London, England)|December 4, 2023
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trialUwe Platzbecker, Valeria Santini, Pierre Fenaux, et al.
Blood Cancer Journal|March 31, 2025
Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched studyAlex Bataller, Koji Sasaki, Samuel Urrutia, et al.
The Lancet. Oncology|August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialHagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Bioinformatics (Oxford, England)|December 6, 2022
Interactive network-based clustering and investigation of multimorbidity association matrices with associationSubgraphsNick Strayer, Siwei Zhang, Lydia Yao, et al.
Pageof 42